Search

everythinglearnresearchcommunity

for

Search:↓

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Type I interferons play a key role in the development of various skin diseases.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.